| Literature DB >> 31109376 |
Sarah O'Neill1, Julia Irani2, Joseph Nelson Siewe Fodjo3, Denis Nono4, Catherine Abbo5, Yasuaki Sato6, Augustine Mugarura7, Housseini Dolo3, Maya Ronse2, Alfred K Njamnshi8, Robert Colebunders3.
Abstract
BACKGROUND: In onchocerciasis-endemic areas, particularly in those with a sub-optimal onchocerciasis control programme, a high prevalence of epilepsy is observed. Both onchocerciasis and epilepsy are stigmatizing conditions. The first international workshop on onchocerciasis-associated epilepsy (OAE) was held in Antwerp, Belgium (12-14 October 2017) and during this meeting, an OAE alliance was established. In this paper, we review what is known about epilepsy-associated stigma in onchocerciasis-endemic regions, and present the recommendations of the OAE alliance working group on stigma. MAIN BODY: For this scoping review, literature searches were performed on the electronic databases PubMed, Scopus and Science Direct using the search terms "epilepsy AND onchocerciasis AND stigma". Hand searches were also undertaken using Google Scholar, and in total seven papers were identified that addressed epilepsy-related stigma in an onchocercisasis-endemic area. Due to the limited number of published research papers on epilepsy-associated stigma in onchocerciasis-endemic areas, other relevant literature that describes important aspects related to stigma is discussed. The thematic presentation of this scoping review follows key insights on the barriers to alleviating the social consequences of stigma in highly affected onchocerciasis-endemic areas, which were established by experts during the working group on stigma and discrimination at the first international workshop on OAE. These themes are: knowledge gaps, perceived disease aetiology, access to education, marriage restrictions, psycho-social well-being, burden on the care-giver and treatment seeking behaviour. Based on the literature and expert discussions during the OAE working group on stigma, this paper describes important issues regarding epilepsy-related stigma in onchocerciasis-endemic regions and recommends interventions that are needed to reduce stigma and discrimination for the improvement of the psycho-social well-being of persons with epilepsy.Entities:
Keywords: Africa; Anti-epileptic treatment; Discrimination; Epilepsy; Misconception; Nodding syndrome; Onchocerciasis; Stigma
Mesh:
Year: 2019 PMID: 31109376 PMCID: PMC6526597 DOI: 10.1186/s40249-019-0544-6
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Measures and interventions to decrease epilepsy stigma
| Recommended Intervention | Aim | How? |
|---|---|---|
| Epilepsy awareness campaign, with emphasis on OAE | Improve knowledge, decrease stigma | - Organize information campaign: locally, nationally, and internationally - Main message: Epilepsy is a non-contagious brain disease, which can be treated (not cured) - In onchocerciasis hyperendemic settings, > 85% of epilepsies are potentially caused by |
| Reduce epilepsy treatment gap | Access to uninterrupted supply of affordable AED | - Decentralize treatment/care services for PWE - Decrease stigma by improving knowledge to stimulate positive health-seeking behavior |
| Reducing knowledge gap about treatment | Improve adherence to AED treatment | - Message: AED treatment should not be interrupted - Discourage treatment using traditional medicine |
| Support for affected families | Improve their quality of life | - Provide psycho-social support for PWE and their families - Organize income-generating activities |
| Training healthcare workers (HCW) | Improve quality of care for PWE | - Set up comprehensive programs to train local HCW for the treatment, care, follow-up and co-morbidity management of PWE [ |
| Training of teachers | Decrease school drop-out rates | - Set up training programs for teachers on how to deal with children with epilepsy |
| Support for community-based associations of PWE | Advocacy to improve the quality of life of PWE and their families | - Involve peer support groups - Use role models - Provide support for associations of PWE |
| Strengthening mental/brain health services and onchocerciasis elimination program | Early diagnosis and initiation of AED treatment. Decrease | - Increase collaboration between both programmes - Set up surveillance system for epilepsy - Monitor the quality of the services for PWE - Improve adherence with CDTI, stressing the importance of taking ivermectin to prevent OAE - Bi-annual CDTI in situations of high exposure to infected blackflies. |
| Strengthening the legal framework | Protect PWE against discrimination, abuse, rape | - Provide legal support for PWE |
| Cost of epilepsy studies | Evaluate the cost-effectiveness of interventions | - Conduct cost-effectiveness studies for epilepsy management in onchocerciasis-endemic areas with high epilepsy prevalence, prior to interventions |
| Fundraising | Increase funding for the treatment and prevention of epilepsy in onchocerciasis-endemic regions | - Establish OAE advocacy strategy - Create awareness about OAE among pharmaceutical companies, NGOs, international funding agencies - Document OAE burden of disease - Dissemination of OAE research findings - Obtain support from WHO, MOH, ILAE |
AED Anti-epileptic drugs, PWE Person(s) with epilepsy, CDTI Community-directed treatment with ivermectin, OAE Onchocerciasis-associated epilepsy, NGOs Non-governmental organizations, WHO World Health Organizition, MOH Ministry of Health, ILAE International league against epilepsy